Nicoccino Holding AB Logo

Nicoccino Holding AB

Develops and markets a patented, dissolvable, tobacco-free nicotine strip.

NICO | ST

Overview

Corporate Details

ISIN(s):
SE0005506185
LEI:
549300C2GLW07PG6ND62
Country:
Sweden
Address:
Gillinge 55, 186 91 Vallentuna

Description

Nicoccino Holding AB develops, manufactures, and markets innovative, tobacco-free nicotine products for adult consumers. The company's core product is a patented, dissolvable nicotine strip. This thin film is placed under the upper lip, where it delivers pharmaceutical-grade nicotine through the oral mucosa within seconds and dissolves completely in a few minutes. This delivery system provides a discreet, convenient, and waste-free alternative to traditional nicotine products, leaving no residue. The strips are clinically tested for safety and efficacy, are made from food-grade ingredients, and have a two-year shelf life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nicoccino Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nicoccino Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nicoccino Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ELUTIA INC. Logo
Develops drug-eluting biomaterials for medical implants and tissue reconstruction.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and delivers medical countermeasures for public health threats and crises.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Biotechnology company developing small molecule drugs for virology and immunology.
United States of America
ENTA
Enervit Logo
Develops sports nutrition, functional foods, and wellness supplements.
Italy
ENV
enGene Holdings Inc. Logo
Clinical-stage biotech developing non-viral gene therapies for local delivery.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
Clinical-stage biopharma developing kinase inhibitors for precision oncology.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
A clinical-stage macrophage reprogramming immunotherapy company.
Israel
ENLV
Enlivex Therapeutics Ltd. Logo
Develops macrophage reprogramming immunotherapy for inflammatory diseases.
United States of America
ENLV
Enorama Pharma AB Logo
Develops and manufactures medicated chewing gums and tobacco-free nicotine pouches.
Sweden
ERMA
Ensol Biosciences Inc. Logo
AI-driven biopharma developing peptide drugs for unmet medical needs.
South Korea
140610

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.